UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): July 25, 2003
PACIFICHEALTH LABORATORIES, INC.
--------------------------------------------------------------------------------
(Exact name of registrant as specified in charter)
Delaware 000-23495 22-3367588
--------- ------------ ----------
(State of other (Commission (IRS Employer
jurisdiction of File Number) Identification
incorporation) Number)
100 Matawan Road, Suite 420 Matawan, NJ 07747-3913
--------------------------------------------------------------------------------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (732) 739-2900
--------------
1480 Route 9 North - Suite 204, Woodbridge, New Jersey 07095
--------------------------------------------------------------
(Former name or former address, if changed since last report.)
Item 7. Financial Statements and Exhibits.
(a) Not applicable.
(b) Not applicable.
(c) Exhibits
Exhibit No. Description
----------- -----------
99.1 Press release dated July 25, 2003.
Item 12. Results of Operations and Financial Condition.
On July 25, 2003, PacificHealth Laboratories, Inc. issued a press
release announcing certain financial results for the fiscal quarter ended June
30, 2003. A copy of the press release is attached hereto as Exhibit 99.1 and
incorporated herein by reference. The information included in the attached
exhibit and contained in Item 12 of this Current Report shall not be deemed
"filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as
amended (the "Exchange Act"), or incorporated by reference in any filing under
the Securities Act of 1933, as amended, or the Exchange Act, except as shall be
expressly incorporated by specific reference in such a filing.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of
1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
PACIFICHEALTH LABORATORIES, INC.
Dated: July 25, 2003 By: /s/ Stephen P. Kuchen
---------------------------------
Stephen P. Kuchen
Chief Financial Officer
Exhibit Index
Exhibit No. Description
----------- -----------
99.1 Press release dated July 25, 2003